Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Cardiometabolic Risk Factors Registry

OBSERVATIONALInicio: 1 de jun de 2015ID: NCT04040777

ReclutandoClinicalTrials.gov

A Registry of Spontaneous Coronary Artery Dissection

OBSERVATIONALInicio: 30 de ene de 2021ID: NCT06601270

ReclutandoFase 3ClinicalTrials.gov

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants

INTERVENTIONALInicio: 16 de feb de 2026ID: NCT07220083

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled (Older Adults, Aged >60 to 79 Years) and Open-Label (Adults, Aged 45 to 60 Years), Multicenter Trial to Investigate the Safety and Immunogenicity of a Dengue Tetravalent Vaccine (TDV) Administered Subcutaneously to Adults and Older Adults With or Without Comorbidities in Endemic Areas for Dengue

INTERVENTIONALInicio: 20 de ene de 2026ID: NCT06579755

ReclutandoClinicalTrials.gov

Characteristics of Patients With Autoimmune Interstitial Lund Disease From Argentina

OBSERVATIONALInicio: 10 de abr de 2022ID: NCT05365009

ReclutandoFase 3ClinicalTrials.gov

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

INTERVENTIONALInicio: 1 de abr de 2013ID: NCT01949129

ReclutandoClinicalTrials.gov

Prospective Multi-country, Real-world, Multi-arm Study of Treatment PErsistence With RISankizumab in Psoriatic Arthritis (PERIS)

OBSERVATIONALInicio: 31 de ene de 2025ID: NCT06764693

ReclutandoClinicalTrials.gov

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

INTERVENTIONALInicio: 23 de jun de 2021ID: NCT04701684

ReclutandoFase 3ClinicalTrials.gov

Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

INTERVENTIONALInicio: 8 de may de 2023ID: NCT05636176

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Open-Label, Phase 3 Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab Versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab as First-Line Treatment in Participants With Unresectable, Locally Advanced or Metastatic HER2-Positive Gastric Or Gastroesophageal Junction (GEJ) Cancer (Destiny-Gastric05)

INTERVENTIONALInicio: 27 de feb de 2025ID: NCT06731478

ReclutandoClinicalTrials.gov

Natural History Study of Synucleinopathies

OBSERVATIONALInicio: 1 de jun de 2011ID: NCT01799915

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's

INTERVENTIONALInicio: 23 de abr de 2025ID: NCT06928142

ReclutandoFase 3ClinicalTrials.gov

A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301

INTERVENTIONALInicio: 20 de sept de 2021ID: NCT04557462

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

INTERVENTIONALInicio: 13 de nov de 2025ID: NCT06804811

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination With Durvalumab, Carboplatin and Etoposide Versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312)

INTERVENTIONALInicio: 18 de ago de 2025ID: NCT07005128

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)

INTERVENTIONALInicio: 30 de jun de 2022ID: NCT05303064

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate-to-severe Ulcerative Colitis

INTERVENTIONALInicio: 28 de mar de 2025ID: NCT06867094

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy

INTERVENTIONALInicio: 21 de ago de 2024ID: NCT06290141

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma

INTERVENTIONALInicio: 22 de oct de 2025ID: NCT07219173

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors

INTERVENTIONALInicio: 11 de jun de 2024ID: NCT06305754